Related Experiment Video
Updated: Jan 10, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Sleep is an opportunity to reduce pregnancy-related severe morbidity and mortality
Ghada Bourjeily1, Bilgay Izci-Balserak2, Naya Habr3
1Department of Medicine, Warren Alpert School of Medicine of Brown University, Providence, RI, USA.
Maternal mortality and severe maternal morbidity have been on an upward trend over the past couple of decades in the USA, contrasting other developed countries. Sleep disturbances are common during pregnancy and vary by group demographics, similarly to severe maternal morbidity. This narrative review focuses on highlighting the association between sleep and sleep impairment with severe maternal morbidity and mortality, as well as with adverse perinatal outcomes, making sleep disturbances a potentially modifiable risk factor for maternal morbidity and mortality. The review will also discuss some sleep interventions that are non-pharmacological and that may hold the prospect for reducing the risk of perinatal outcomes associated with severe maternal morbidity and mortality, without increasing the risk of teratogenicity. We also discuss knowledge gaps and potential focus of future research from testing the impact of sleep modification on pregnancy outcomes to the identification of sleep disturbances and disorders in perinatal care.
Maternal mortality and severe maternal morbidity have been on an upward trend over the past couple of decades in the USA, contrasting other developed countries. Sleep disturbances are common during pregnancy and vary by group demographics, similarly to severe maternal morbidity. This narrative review focuses on highlighting the association between sleep and sleep impairment with severe maternal morbidity and mortality, as well as with adverse perinatal outcomes, making sleep disturbances a potentially modifiable risk factor for maternal morbidity and mortality. The review will also discuss some sleep interventions that are non-pharmacological and that may hold the prospect for reducing the risk of perinatal outcomes associated with severe maternal morbidity and mortality, without increasing the risk of teratogenicity. We also discuss knowledge gaps and potential focus of future research from testing the impact of sleep modification on pregnancy outcomes to the identification of sleep disturbances and disorders in perinatal care.
More Related Videos
Related Concept Videos
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Birth Control Methods
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

